Free Trial
NYSE:ITGR

Integer Q2 2025 Earnings Report

Integer logo
$122.73 +0.86 (+0.70%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$122.57 -0.16 (-0.13%)
As of 06/27/2025 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Integer EPS Results

Actual EPS
N/A
Consensus EPS
$1.57
Beat/Miss
N/A
One Year Ago EPS
N/A

Integer Revenue Results

Actual Revenue
N/A
Expected Revenue
$464.37 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Integer Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, July 24, 2025
Conference Call Time
9:00AM ET

Conference Call Resources

Integer Earnings Headlines

ITGR - Integer Holdings Corp Sustainability | Morningstar
Trump Knows Exactly What He’s Doing…
With Trump in office, new money is flowing in and out of the market like never before... And some folks using my strategy are making a fast fortune... no matter which way the market moves. This is the same one-ticker strategy I used to make more $95 million in verified profits for my clients during the 2008 financial crisis. But now... with Trump sending about $240 billon into the markets every week on specific, pre-determined dates...
Integer Holdings: Major Changes Afoot In 2025
See More Integer Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Integer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Integer and other key companies, straight to your email.

About Integer

Integer (NYSE:ITGR) operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

View Integer Profile

More Earnings Resources from MarketBeat